Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats. 2014

Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
Science and Arts Faculty, Department of Biology, Artvin Coruh University, 08000, Artvin, Turkey, gbayramoglu@artvin.edu.tr.

Little is known about the protective effects of carvacrol on the symptoms of streptozotocin induced diabetes in rats. Hence, this present study was designed to evaluate the protective effect of the strong antioxidant, carvacrol, on the symptoms of streptozotocin induced diabetes in rats. Carvacrol at the doses of 25 and 50 mg/kg body weight were orally administered to diabetic rats for a period of 7 days after the onset of diabetes. Food-water intake and body weight changes were daily recorded. Biochemical parameters such as serum glucose, insulin, total cholesterol, alanine aminotransferase, aspartate aminotransferase and lactate dehydrogenase were measured. Although treatment of diabetic rats with oral administration of carvacrol resulted in a slight reduction in serum glucose level and significant reduction in serum total cholesterol, alanine aminotransferase, aspartate aminotransferase and lactate dehydrogenase in comparison with diabetic control rats, there were no significant differences in serum insulin levels, food-water intake values and body weight changes. Despite the inadequacy of carvacrol on diabetes treatments, it was determined to have at least a partially protective role on liver enzymes.

UI MeSH Term Description Entries

Related Publications

Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
January 2023, Current pharmaceutical biotechnology,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
April 1993, Diabetes,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
January 1995, Diabetes research and clinical practice,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
September 2023, Applied biochemistry and biotechnology,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
January 2011, Evidence-based complementary and alternative medicine : eCAM,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
June 2021, Journal of diabetes and metabolic disorders,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
August 2012, Journal of medicinal food,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
February 1992, Diabetes,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
November 2014, European review for medical and pharmacological sciences,
Gokhan Bayramoglu, and Hakan Senturk, and Aysegul Bayramoglu, and Mustafa Uyanoglu, and Suat Colak, and Ayse Ozmen, and Durdane Kolankaya
March 1992, Diabetes,
Copied contents to your clipboard!